Influenza vaccination status in rheumatoid arthritis and spondyloarthritis patients receiving biologic DMARDs

Murielle Michel; Fabien B Vincent; Simon Rio; Nathalie Leon; Christian Marcelli

doi:10.1016/j.jbspin.2015.02.016

Influenza vaccination status in rheumatoid arthritis and spondyloarthritis patients receiving biologic DMARDs

Joint Bone Spine. 2016 Mar;83(2):237-8. doi: 10.1016/j.jbspin.2015.02.016. Epub 2015 Jul 17.

Authors

Murielle Michel¹, Fabien B Vincent², Simon Rio³, Nathalie Leon³, Christian Marcelli³

Affiliations

¹ Department of Rheumatology, University Hospital Centre of Caen, avenue de la Côte-de-Nacre, 14033 Caen cedex 9, France. Electronic address: michel-m@chu-caen.fr.
² Department of Immunology, Monash University, Central Clinical School, Alfred Medical Research and Education Precinct (AMREP), 89 Commercial Road, Melbourne, Victoria 3004, Australia.
³ Department of Rheumatology, University Hospital Centre of Caen, avenue de la Côte-de-Nacre, 14033 Caen cedex 9, France.

PMID: 26190453
DOI: 10.1016/j.jbspin.2015.02.016

No abstract available

Keywords: Biologics; Chronic inflammatory rheumatic disease (CIRD); Disease-modifying antirheumatic drugs (DMARDs); Influenza vaccination; Patient information.

Publication types

Letter

MeSH terms

Aged
Antirheumatic Agents / therapeutic use*
Arthritis, Rheumatoid / drug therapy*
Biological Products / therapeutic use*
Female
Humans
Influenza Vaccines / administration & dosage*
Influenza Vaccines / therapeutic use
Influenza, Human / prevention & control
Male
Middle Aged
Spondylarthritis / drug therapy
Vaccination

Substances

Antirheumatic Agents
Biological Products
Influenza Vaccines